Michael Kalb | executive |
Richard John Daly | executive |
Jeffrey Del Carmen | executive |
Charles Duncan | analyst |
Samantha Semenkow | analyst |
Steven Miller | executive |
Jason Gerberry | analyst |
Leland Gershell | analyst |
Joseph Catanzaro | analyst |
Greetings, and welcome to the Catalyst Pharmaceuticals' Second Quarter 2024 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Michael Kalb, CFO. Thank you, Michael.
You may begin.
Thank you.